🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/06/2018 | 112,50 | 112,69 | 108,27 | 108,46 | -3,28% | 3,93% | 213.000 |
| 26/06/2018 | 113,88 | 113,88 | 111,19 | 112,14 | -1,20% | 2,36% | 314.800 |
| 25/06/2018 | 116,24 | 117,00 | 113,06 | 113,50 | -2,55% | 3,39% | 274.700 |
| 22/06/2018 | 117,23 | 118,14 | 115,53 | 116,47 | -0,22% | 2,23% | 394.700 |
| 21/06/2018 | 118,17 | 118,17 | 115,89 | 116,73 | -1,34% | 1,93% | 190.200 |
| 20/06/2018 | 117,35 | 118,56 | 116,49 | 118,31 | +0,70% | 1,76% | 251.400 |
| 19/06/2018 | 114,78 | 117,70 | 114,78 | 117,49 | +1,67% | 2,54% | 237.800 |
| 18/06/2018 | 116,03 | 118,59 | 114,07 | 115,56 | -1,51% | 3,90% | 332.900 |
| 15/06/2018 | 114,35 | 118,00 | 111,56 | 117,33 | +2,77% | 5,63% | 791.800 |
| 14/06/2018 | 112,84 | 114,35 | 111,71 | 114,17 | +1,39% | 2,34% | 282.200 |
| 13/06/2018 | 113,38 | 113,84 | 111,90 | 112,61 | -0,27% | 1,71% | 233.200 |
| 12/06/2018 | 112,29 | 113,26 | 111,34 | 112,91 | +0,34% | 1,71% | 392.900 |
| 11/06/2018 | 112,10 | 113,29 | 111,95 | 112,53 | +0,57% | 1,20% | 183.600 |
| 08/06/2018 | 110,45 | 112,01 | 109,95 | 111,89 | +0,84% | 1,87% | 358.300 |
| 07/06/2018 | 111,04 | 112,11 | 110,03 | 110,96 | +0,25% | 1,87% | 213.900 |
| 06/06/2018 | 108,56 | 111,59 | 107,80 | 110,68 | +2,01% | 3,49% | 336.700 |
| 05/06/2018 | 110,05 | 110,73 | 108,02 | 108,50 | -1,24% | 2,46% | 227.000 |
| 04/06/2018 | 107,63 | 110,10 | 107,28 | 109,86 | +2,68% | 2,62% | 338.400 |
| 01/06/2018 | 107,36 | 108,34 | 106,27 | 106,99 | +0,38% | 1,93% | 349.200 |
| 31/05/2018 | 107,85 | 107,85 | 105,65 | 106,58 | -1,63% | 2,04% | 432.400 |
| 30/05/2018 | 105,25 | 108,72 | 105,19 | 108,35 | +2,94% | 3,35% | 390.800 |
| 29/05/2018 | 103,14 | 105,67 | 102,70 | 105,26 | +1,60% | 2,88% | 262.200 |
| 25/05/2018 | 104,82 | 107,24 | 103,57 | 103,60 | -1,08% | 3,50% | 215.800 |
| 24/05/2018 | 105,58 | 107,34 | 104,31 | 104,73 | -0,79% | 2,87% | 198.300 |
| 23/05/2018 | 104,35 | 106,61 | 103,97 | 105,56 | +0,46% | 2,53% | 211.200 |
| 22/05/2018 | 104,09 | 106,65 | 104,09 | 105,08 | +0,92% | 2,46% | 215.400 |
| 21/05/2018 | 106,83 | 106,94 | 104,00 | 104,12 | -2,02% | 2,75% | 300.800 |
| 18/05/2018 | 107,67 | 108,42 | 106,11 | 106,27 | -1,33% | 2,15% | 348.300 |
| 17/05/2018 | 108,44 | 108,80 | 107,33 | 107,70 | -1,11% | 1,36% | 363.000 |
| 16/05/2018 | 107,40 | 110,05 | 106,12 | 108,91 | +1,74% | 3,66% | 318.500 |